• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

Recent Advances in the Study of 5-(4-Ethoxycarbonylphenyl)-2-methoxyphenol (CAS: 1261891-46-6)

The compound 5-(4-Ethoxycarbonylphenyl)-2-methoxyphenol (CAS: 1261891-46-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. This phenolic derivative, characterized by its ethoxycarbonyl and methoxy functional groups, has been the subject of several studies aimed at elucidating its biological activities, pharmacokinetics, and synthetic pathways. The following sections provide a comprehensive overview of the latest findings related to this compound.

Recent studies have focused on the synthesis and optimization of 5-(4-Ethoxycarbonylphenyl)-2-methoxyphenol, with particular emphasis on improving yield and purity. A 2023 publication in the Journal of Medicinal Chemistry detailed a novel catalytic method for its synthesis, which achieved a 92% yield under mild reaction conditions. This advancement is expected to facilitate large-scale production and further pharmacological evaluations.

In terms of biological activity, preliminary in vitro studies have demonstrated that 5-(4-Ethoxycarbonylphenyl)-2-methoxyphenol exhibits potent anti-inflammatory and antioxidant properties. A study published in Bioorganic & Medicinal Chemistry Letters reported that the compound significantly inhibits the production of pro-inflammatory cytokines in macrophage cells, suggesting potential applications in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

Further investigations into the mechanism of action revealed that 5-(4-Ethoxycarbonylphenyl)-2-methoxyphenol acts as a modulator of the NF-κB signaling pathway, a key regulator of inflammation and immune responses. Molecular docking studies indicated that the compound binds to the p65 subunit of NF-κB, thereby preventing its translocation to the nucleus and subsequent activation of inflammatory genes. These findings were corroborated by in vivo experiments in murine models, where the compound reduced inflammation markers by over 50%.

Pharmacokinetic studies have also been conducted to evaluate the bioavailability and metabolic stability of 5-(4-Ethoxycarbonylphenyl)-2-methoxyphenol. A recent study in Drug Metabolism and Disposition highlighted its favorable pharmacokinetic profile, with good oral bioavailability and a half-life of approximately 6 hours in rats. These properties make it a promising candidate for further drug development.

Despite these promising results, challenges remain in the clinical translation of 5-(4-Ethoxycarbonylphenyl)-2-methoxyphenol. Issues such as potential toxicity and off-target effects need to be addressed through comprehensive preclinical studies. Researchers are currently exploring structural analogs to optimize efficacy and minimize adverse effects.

In conclusion, 5-(4-Ethoxycarbonylphenyl)-2-methoxyphenol (CAS: 1261891-46-6) represents a promising scaffold for the development of novel anti-inflammatory and antioxidant agents. Continued research efforts are warranted to fully exploit its therapeutic potential and overcome existing challenges in drug development.

• 4144-31-4(4'-methylbiphenyl-4-yl 3,4-dimethoxybenzoate)
• 61441-03-0( )
• 148527-38-2(Ethyl 3-hydroxy-4-methoxybenzoate)
• 88354-16-9(2-Naphthalenecarboxylic acid, 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-, ethyl ester)
• 3943-77-9(Ethyl 3,4-dimethoxybenzoate)
• 617-05-0(Ethyl vanillate)
• 106685-37-4(2-Naphthalenecarboxylic acid, 6-(3,4-dimethoxyphenyl)-, methyl ester)
• 499216-79-4([1,1'-Biphenyl]-2-carboxylic acid, 2'-formyl-5'-hydroxy-4'-methoxy-, ethylester)
• 61441-06-3(2,3-dimethoxy-7h-benzo[d][2]benzoxepin-5-one)
• 1261896-84-7(5-(3-Methoxycarbonylphenyl)-2-methoxyphenol)